YM178
YM178 is a pharmaceutical drug with 11 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 11 completed trials
Phase Distribution
Phase Distribution
5
Early Stage
3
Mid Stage
3
Late Stage
Highest Phase Reached
Phase 3Trial Status & Enrollment
100.0%
11 of 11 finished
0.0%
0 ended early
0
trials recruiting
11
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
A Study of YM178 in Patients With Symptomatic Overactive Bladder
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients
Clinical Trials (11)
A Study of YM178 in Subjects With Symptoms of Overactive Bladder
A Study of YM178 in Patients With Symptomatic Overactive Bladder
Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder
A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder
A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients
A Pharmacokinetic Study of YM178 in Normal Subjects and Those With Mild, Moderate, and Severe Renal Impairment
A Study to Investigate the Food Effect on the Pharmacokinetics of YM178 in Healthy, Non-elderly Volunteers
A Clinical Study to Determine the Effect of YM178 on the Pharmacokinetics of Warfarin in Healthy Subjects
A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)
A Study to Investigate the Safety and Effect of Food on the Pharmacokinetics of YM178 in Healthy Volunteers
Study to Assess the Safety and Plasma Concentration of YM178 OCAS Tablet (Mirabegron) in Healthy Chinese Volunteers
All 11 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 11